3 Canadian Stocks to Buy in a Donald Trump World

A Trump presidency is good news for TransCanada Corporation (TSX:TRP)(NYSE:TRP), Barrick Gold Corp. (TSX:ABX)(NYSE:ABX), and one other stock.

| More on:
The Motley Fool

It’s official. Republican Donald Trump has defeated Democrat Hillary Clinton and will be the next president of the United States.

At first, markets were shocked by the news. Dow Jones Industrial Average futures fell close to 1,000 points as Trump locked in votes, which would have represented a bigger crash than immediately after the 9/11 terrorist attacks. Investors panicked, convinced a Trump presidency would be bad for free trade, economic growth, and foreign investment.

But investors calmed down, and major U.S. and Canadian indices hit positive territory during today’s trading. Trump’s victory speech didn’t even mention many of the issues that first alarmed investors, and many began talking about some of Trump’s pro-business policies having a big impact, like cutting corporate taxes to 15% and encouraging multi-national corporations to bring earnings trapped overseas home.

A Trump presidency can also be good for Canadian stocks. Here are three that should be happy with his victory.

TransCanada 

A Trump win is likely very good news for TransCanada Corporation (TSX:TRP)(NYSE:TRP).

Remember, the company was all set to build its Keystone XL pipeline through the heart of the United States before President Obama gave into political pressure and vetoed the project in November 2015. Oh, what a difference a year makes.

Keystone XL seems much more likely to pass under a Trump administration. It was part of his platform, and the president-elect even tweeted about it personally. Trump is also much more pro-energy than the current administration, favouring a plan to make America energy independent by encouraging domestic production. That’s good news for a pipeline company with many of its assets in the U.S.

Don’t be surprised if one of his first moves as president is to ask TransCanada to send its application back in.

Gold

One of the hottest sectors on the Toronto Stock Exchange is gold, as investors think a Trump presidency is good news for the price of the yellow metal.

The logic goes something like this.

Investors are worried Trump will pass a number of laws that are bad for the U.S. dollar. He constantly spoke about slapping tariffs on various imports in an effort to keep manufacturing jobs at home. Anti-trade laws tend to be bad news for the U.S. dollar. Capital leaves a country with such policies.

Gold does well in such a situation. Investors run to so-called safe-haven assets.

Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) is a clear beneficiary in a world where the price of gold is increasing. That’s because the company has massive operating leverage. If gold goes up, Barrick benefits quite a bit. Every gold miner benefits, but Barrick has high costs and a lot of debt. It benefits the most.

Valeant

A Trump victory is also a plus for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), a company that really needs at least one thing to go its way.

Valeant is dealing with many different issues. It has a mountain of debt. Former execs have been named in a criminal probe after the Philidor scandal. And it could face increased competition as some of its major drugs will no longer be protected.

Clinton’s campaign targeted drug makers like Valeant, vowing to take a serious look at rapidly increasing prices. Trump’s campaign barely said a peep.

Valeant is hardly out of the woods yet. But shares are up 3.6% during Wednesday’s trading session as investors are relieved it will have one less issue to deal with.

The bottom line

For the most part, investors shouldn’t care at all about Tuesday’s election results. It’s business as usual for most North American companies until Trump proves otherwise.

But there are a few that will benefit from the current situation. Will it be enough to justify purchasing any of these companies? That’s up to each individual investor to decide.

 

Fool contributor Nelson Smith has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

hand stacks coins
Dividend Stocks

3 Canadian Stocks That Could Be an Ideal Fit for a $7,000 TFSA Investment

A balanced TFSA portfolio starts with the right stocks -- here are three strong contenders.

Read more »

Real estate investment concept
Dividend Stocks

A Reliable Monthly Dividend Stock With a 4.5% Yield Worth Considering

Morguard North American Residential REIT (TSX:MRG.UN) offers a compelling 4.5% yield as it transforms from high-risk payer to blue-chip contender…

Read more »

man in suit looks at a computer with an anxious expression
Dividend Stocks

If I Could Only Buy and Hold a Single Stock, This Would Be It

Thomson Reuters has quietly doubled its financials since 2019. With AI tailwinds, a fortress balance sheet, and 9% legal growth,…

Read more »

man crosses arms and hands to make stop sign
Dividend Stocks

The Dividend Stock I Own and Have Zero Intention of Ever Selling

Here's why this dividend stock isn't just one of the best to buy on the TSX, but one you'll never…

Read more »

hot air balloon in a blue sky
Dividend Stocks

3 Canadian Stocks That Could Benefit From a Softer Economy

These three TSX names try to defend a portfolio in a softer economy with essential demand, monthly income, or a…

Read more »

dividends can compound over time
Dividend Stocks

2 Undervalued Canadian Stocks to Buy Before Investors Catch On

Interfor and ECN look “undervalued” mainly because investors are impatient with a bad cycle or messy deal optics, not because…

Read more »

woman holding steering wheel is nervous about the future
Dividend Stocks

4 Canadian Stocks Worth Holding When Market Anxiety Starts to Rise

These Canadian stocks are some of the best and most reliable companies to own as volatility and uncertainty start to…

Read more »

cookies stack up for growing profit
Dividend Stocks

3 Top TSX Stocks to Buy if You Want Stability and Growth

These three TSX names aim to balance “sleep-at-night” qualities with enough growth levers to keep returns compounding.

Read more »